Ignite Creation Date:
2025-12-24 @ 6:39 PM
Ignite Modification Date:
2026-04-18 @ 4:12 AM
Study NCT ID:
NCT03071757
Status:
COMPLETED
Last Update Posted:
2022-04-28
First Post:
2017-03-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-02
First Submit QC Date:
None
Study First Post Date:
2017-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-21
Last Update Post Date:
2022-04-28
Last Update Post Date Type:
ACTUAL